Pranoprofen
PRATTACK is an eye drop solution containing pranoprofen as the active substance, a medicine with anti-inflammatory properties. PRATTACK is indicated for the treatment of acute and chronic non-infectious inflammatory eye diseases (blepharitis, conjunctivitis, blepharoconjunctivitis, anterior uveitis) and post-operative anti-inflammatory treatment after surgeries in the anterior segment of the eye (after cataract removal).
If you are allergic to pranoprofen or any of the other ingredients of this medicine (listed in section 6). In children under 2 years of age (see "PRATTACK contains boron").
Before starting to use PRATTACK, discuss it with your doctor or pharmacist. Wait at least 5 minutes after administering PRATTACK before administering another eye medicine.
No adverse interactions between PRATTACK and other medicines have been reported so far, however, you should tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. Pregnancy The safety of PRATTACK in pregnancy has not been established. PRATTACK should only be used during pregnancy under close medical supervision and only if the doctor considers it necessary. Breastfeeding No controlled clinical studies have been conducted on the use of PRATTACK in breastfeeding women. PRATTACK should only be used during breastfeeding under close medical supervision and only if the doctor considers it necessary.
Using PRATTACK has no effect on the ability to drive or operate machinery. However, remember that putting any eye drops into your eyes may cause temporary blurred vision. Additionally, the diseases for which PRATTACK is indicated may impair vision and thus affect the ability to drive or operate machinery. PRATTACK contains benzalkonium chloride(a preservative) The medicine contains 0.07 mg of benzalkonium chloride per milliliter of solution. Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lenses before administering the drops and wait at least 15 minutes before putting them back. Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If you experience any abnormal sensations in the eye, stinging, or eye pain after using the medicine, contact your doctor.
Do not use in children under 2 years of age due to the presence of boron, which may cause fertility disorders (see "When not to use PRATTACK").
Dosage PRATTACK should always be used exactly as your doctor has instructed. If you are unsure, ask your doctor. The usual dose is 2 drops into the affected eye(s) every 6 hours. The duration of treatment is determined by your doctor. Method of administration:
The product should not be used by more than one person. It should be administered under the best possible hygiene conditions. Any other eye medicine can be administered only after waiting at least 5 minutes after administering PRATTACK.
Given the nature of the medicine, which is intended for local administration to the eyes, it is unlikely to expect toxic effects associated with its use in recommended doses or in case of accidental ingestion. Nevertheless, if you have taken more than the recommended dose of PRATTACK or if you have accidentally ingested it, contact your doctor or pharmacist.
If you miss a dose, resume your normal dosing schedule as soon as possible. Do not take a double dose to make up for a missed dose.
Like all medicines, PRATTACK can cause side effects, although not everybody gets them. Some patients have experienced: conjunctival hyperemia, itching, eyelid edema, foreign body sensation, irritation, or tearing. The frequency of these side effects is unknown (cannot be estimated from the available data). Reporting side effects If you experience any side effects, including any not listed in this leaflet, please tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, e-mail: ndl@urpl.gov.pl Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the packaging. Shelf-life after first opening the bottle: 4 weeks. Store in a temperature below 25°C. Protect from light.
PRATTACK is a clear, colorless solution. The pack contains one bottle of PRATTACK containing 5 ml of solution.
Senju Poland Sp. z o.o. Rondo Ignacego Daszyńskiego 2B, 00-843 Warsaw tel.: +48 22 236 05 05 e-mail: office@senju-pl.com
PROFARM PS Sp. z o.o. ul. Słoneczna 96 05-500 Stara Iwiczna Poland Synoptis Industrial Sp. z o.o. ul. Rabowicka 15 62-020 Swarzędz Date of last revision of the leaflet:07/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.